Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neural cell repair is a complex, multi-stage physiological process aimed at restoring the structural integrity and functional connectivity of the nervous system following injury or disease. Rather than a single molecular target like a receptor or enzyme, it represents a broad therapeutic objective that encompasses neurogenesis, axonal regrowth, remyelination, and the re-establishment of synaptic connections. The process is regulated by a delicate balance of intrinsic growth signals, such as neurotrophic factors (e.g., BDNF, NGF), and extrinsic inhibitory factors in the glial scar, such as Nogo-A or chondroitin sulfate proteoglycans (CSPGs). In drug discovery, researchers target specific components of this process to treat conditions like spinal cord injury, traumatic brain injury, and multiple sclerosis. Because the term describes a biological outcome rather than a discrete molecule, it is considered a therapeutic category or physiological state.
Not applicable as this is a biological process/therapeutic outcome rather than a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neural cell repair.